| __timestamp | ADMA Biologics, Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 35942000 |
| Thursday, January 1, 2015 | 6745968 | 40028000 |
| Friday, January 1, 2016 | 8494742 | 45853000 |
| Sunday, January 1, 2017 | 18092835 | 53816000 |
| Monday, January 1, 2018 | 22502922 | 60804000 |
| Tuesday, January 1, 2019 | 25910757 | 77252000 |
| Wednesday, January 1, 2020 | 35050817 | 45736000 |
| Friday, January 1, 2021 | 42896889 | 50323000 |
| Saturday, January 1, 2022 | 52458024 | 143526000 |
| Sunday, January 1, 2023 | 59020000 | 149182000 |
| Monday, January 1, 2024 | 154335000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Halozyme Therapeutics, Inc. and ADMA Biologics, Inc. have shown contrasting approaches. From 2014 to 2023, Halozyme's SG&A expenses surged by approximately 315%, peaking at $149 million in 2023. In contrast, ADMA Biologics saw a more modest increase of around 1,125%, reaching $59 million in the same year.
While Halozyme's expenses are significantly higher, their growth strategy might justify these costs. ADMA's more conservative spending could indicate a focus on efficiency. Investors and stakeholders should consider these trends when evaluating each company's financial strategy and potential for sustainable growth.
Comparing SG&A Expenses: Eli Lilly and Company vs Halozyme Therapeutics, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or ADMA Biologics, Inc.
Breaking Down SG&A Expenses: AbbVie Inc. vs Halozyme Therapeutics, Inc.
AstraZeneca PLC vs ADMA Biologics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Halozyme Therapeutics, Inc.
Catalent, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs ADMA Biologics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Halozyme Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Halozyme Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: ADMA Biologics, Inc. vs CRISPR Therapeutics AG
Who Optimizes SG&A Costs Better? ADMA Biologics, Inc. or Evotec SE